This page shows current and upcoming funding opportunities supported by the Special Diabetes Program. For other NIH funding opportunities, please see the NIH Guide for Grants and Contracts. Research funding opportunities may also be available through the JDRF , the Helmsley Trust , and the American Diabetes Association .
View archived research funding opportunities.
- Bioengineering Interdisciplinary Training for Diabetes Research (T32)
PAR-13-047
Posted Date: December 17, 2012
Open Date (Earliest Submission Date): February 7, 2013
Letter of Intent Due Dates February 7, 2013 and October 26, 2013
Application Receipt Dates: March 7, 2013 and November 26, 2013, by 5:00 PM local time of applicant organization
- Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artifical Pancreas [SBIR (R43/R44)]
RFA-DK-13-001
Posted Date: December 17, 2012
Open Date (Earliest Submission Date): February 6, 2013
Letter of Intent Due Date: February 6, 2013
Application Receipt Date: March 6, 2013 by 5:00PM local time of applicant organization
- Diabetes Impact Award-Closed Loop Technologies: Clinical, Physiological and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (DP3)
RFA-DK-12-020
Posted Date: December 12, 2012
Open Date (Earliest Submission Date): February 28, 2013
Letter of Intent Due Date: February 28, 2013
Application Receipt Date: March 28, 2013 by 5:00PM local time of applicant organization
- Diabetes Impact Award-Closed Loop Technologies: Development and Integration of Novel Components for an Automated Artificial Pancreas System (DP3)
RFA-DK-12-021
Posted Date: December 12, 2012
Open Date (Earliest Submission Date): February 28, 2013
Letter of Intent Due Date: February 28, 2013
Application Receipt Date: March 28, 2013 by 5:00PM local time of applicant organization
- Research Using Subjects From Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3)
PAR-13-028
Posted Date: November 27, 2012
Open Date (Earliest Submission Date): March 2, 2013
Letter of Intent Due Date: March 2, 2013
Application Receipt Date: April 2, 2013, by 5:00 PM local time of applicant organization
- Collaborative Network for Clinical Research on Immune Tolerance (UM1)
RFA-AI-12-043
Posted Date: November 5, 2012
Letter of Intent Due Date: February 7, 2013
Application Receipt Date: March 7, 2013
- Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3)
PAR-13-013
Posted Date: October 30, 2012
Open Date (Earliest Submission Date): March 2, 2013
Letter of Intent Due Date: March 2, 2013
Application Receipt Date: April 2, 2013, by 5:00 PM local time of applicant organization
- Diabetic Complications Consortium Preclinical Testing Program
Application Receipt Date: There is no formal deadline, but applications will be reviewed quarterly (March 1, June 1, September 1, December 1) and so should be submitted accordingly
Upcoming
- None at this time.